These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27736017)

  • 1. Uncertainty of current algorithm for bisphosphonate-related osteonecrosis of the jaw in population-based studies: a systematic review.
    Kim HY; Kim JW; Kim SJ; Lee SH; Lee HS
    J Bone Miner Res; 2017 Mar; 32(3):584-591. PubMed ID: 27736017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Database analysis of the risk factors of bisphosphonate-related osteonecrosis of the jaw in Hungarian patients.
    Veszelyné Kotán E; Bartha-Lieb T; Parisek Z; Meskó A; Vaszilkó M; Hankó B
    BMJ Open; 2019 May; 9(5):e025600. PubMed ID: 31122970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate.
    Ulmner M; Jarnbring F; Törring O
    J Oral Maxillofac Surg; 2014 Jan; 72(1):76-82. PubMed ID: 23992777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases.
    Pelaz A; Junquera L; Gallego L; García-Consuegra L; García-Martínez L; Cutilli T; Olay S
    Acta Otorrinolaringol Esp; 2015; 66(3):139-47. PubMed ID: 25308796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review.
    Fliefel R; Tröltzsch M; Kühnisch J; Ehrenfeld M; Otto S
    Int J Oral Maxillofac Surg; 2015 May; 44(5):568-85. PubMed ID: 25726090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an ICD-10 algorithm to detect osteonecrosis of the jaw among cancer patients in the Danish National Registry of Patients.
    Ehrenstein V; Gammelager H; Schiødt M; Nørholt SE; Neumann-Jensen B; Folkmar TB; Pedersen L; Svaerke C; Sørensen HT; Ma H; Acquavella J
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):693-700. PubMed ID: 25974710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate-related osteonecrosis of the jaw: data from the French national pharmacovigilance database.
    de Boissieu P; Gaboriau L; Morel A; Trenque T
    Fundam Clin Pharmacol; 2016 Oct; 30(5):450-8. PubMed ID: 27315575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
    Yuh DY; Chang TH; Huang RY; Chien WC; Lin FG; Fu E
    J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of bisphosphonate-related osteonecrosis of the jaw in patients with Sjögren's syndrome: nationwide population-based cohort study.
    Liao MT; Chien WC; Wang JC; Chung CH; Chu SJ; Tsai SH
    BMJ Open; 2019 Feb; 9(2):e024655. PubMed ID: 30765404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?
    Lescaille G; Coudert AE; Baaroun V; Javelot MJ; Cohen-Solal M; Berdal A; Goudot P; Azérad J; Ruhin B; Descroix V
    J Rheumatol; 2013 Jun; 40(6):781-6. PubMed ID: 23504384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the utility of serum C-telopeptide cross-link of type 1 collagen as a predictor of bisphosphonate-related osteonecrosis of the jaw: A systematic review and meta-analysis.
    Enciso R; Keaton J; Saleh N; Ahmadieh A; Clark GT; Sedghizadeh PP
    J Am Dent Assoc; 2016 Jul; 147(7):551-560.e11. PubMed ID: 27040417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC).
    Thomas C; Spanidis M; Engel C; Roos FC; Frees S; Neisius A; Hampel C; Rubenwolf P; Thüroff JW; Walter C; Miederer M
    Clin Oral Investig; 2016 May; 20(4):753-8. PubMed ID: 26307268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
    Del Fabbro M; Gallesio G; Mozzati M
    Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology.
    Fusco V; Santini D; Armento G; Tonini G; Campisi G
    Expert Opin Drug Saf; 2016 Jul; 15(7):925-35. PubMed ID: 27074901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.
    Koth VS; Figueiredo MA; Salum FG; Cherubini K
    Dentomaxillofac Radiol; 2016; 45(7):20160049. PubMed ID: 27167455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of an algorithm to identify osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Danish National Registry of Patients.
    Gammelager H; Sværke C; Noerholt SE; Neumann-Jensen B; Xue F; Critchlow C; Bergdahl J; Lagerros YT; Kieler H; Tell GS; Ehrenstein V
    Clin Epidemiol; 2013; 5():263-7. PubMed ID: 23946670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.
    Utreja A; Almas K; Javed F
    Odontostomatol Trop; 2013 Jun; 36(142):38-46. PubMed ID: 24073539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients having undergone autologous stem cell transplantation.
    Then C; Hörauf N; Otto S; Pautke C; von Tresckow E; Röhnisch T; Baumann P; Schmidmaier R; Bumeder I; Oduncu FS
    Onkologie; 2012; 35(11):658-64. PubMed ID: 23147542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.